Could CAR-T therapy ease severe skin tightening in sclerosis?

NCT ID NCT06792344

First seen Jan 05, 2026 · Last updated Jun 08, 2026 · Updated 25 times

Summary

This early-phase study tests whether a type of immune cell therapy called CAR-T can safely help people with severe systemic sclerosis that hasn't responded to standard treatments. The therapy targets CD19 on immune cells to reduce disease activity. Up to 12 participants aged 5 and older will receive the treatment and be monitored for changes in skin thickness and other symptoms over 6 to 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital, Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 0571, China

    Contact

  • Children's Hospital, Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310053, Christmas Island

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.